Predicting the impact of low-density lipoprotein cholesterol lowering through different drug targets on risk of congenital heart disease

28 August 2023 (09:30 - 09:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Maddalena Ardissino

Royal Papworth Hospital, Cambridge (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Risk stratification of non-cardiac surgeries in adult congenital heart disease

Doctor A. Friedrich (Muenster, DE)

Abstract Slides Video

Presentation thumbnail

Fractional flow reserve in anomalous aortic origin of coronary arteries to evaluate hemodynamic consequences of high risk anatomical features.

Mr D. Verheijen (Leiden, NL)

Abstract Slides Video

Presentation thumbnail

Neo-aortic dimensions and coronary take-off angle in adolescent and young adult patients with transposition of the great arteries after the arterial switch operation

Mr D. Verheijen (Leiden, NL)

Abstract Slides Video

Presentation thumbnail

Temporal trend in hospitalization among patients with congenital heart disease in Denmark: a nationwide study

Doctor C. Lim (Copenhagen, DK)

Abstract Slides Video

Access the full session

Session thumbnail

New findings in adult congenital heart disease

The Event

Event poster

ESC Congress 2023

28 August 2023 09:30 CET

You may be interested in

Congress Session

Predicting and managing maternal cardiovascular risk during pregnancy

Congress Session

What's new in lipid lowering?

Congress Presentation

Genetically determined lipoprotein(a) levels do not cause an increased risk of preeclampsia - a two-sample Mendelian randomization study.

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources